The Biotech Growth Trust PLC reported earnings results for the full year ended March 31, 2022. For the full year, the company reported net loss was GBP 202.42 million compared to net income of GBP 200.43 million a year ago. Basic loss per share from continuing operations was GBP 4.885 compared to basic earnings per share from continuing operations of GBP 5.005 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
937 GBX | +1.19% | +0.64% | +4.81% |
Mar. 26 | Biotech Group Acquisition Withdraws IPO | DJ |
2023 | Biotech Growth's total return underperforms benchmark in tough market | AN |
1st Jan change | Capi. | |
---|---|---|
+4.81% | 390M | |
+3.27% | 14.32B | |
+3.12% | 6.21B | |
+12.72% | 4.4B | |
+10.97% | 4.36B | |
-7.52% | 4B | |
+3.61% | 3.51B | |
+8.55% | 3.21B | |
+7.91% | 3.06B | |
-1.91% | 2.77B |
- Stock Market
- Equities
- BIOG Stock
- News The Biotech Growth Trust PLC
- The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2022